Share-based Payment Arrangement, Expense in USD of Estrella Immunopharma, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Estrella Immunopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q4 2022 to Q3 2025.
  • Estrella Immunopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $152K.
  • Estrella Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.19M, a 192% increase from 2023.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Estrella Immunopharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $152K +$152K 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $159K 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $159K 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q3 2024 $0 -$1.19M -100% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q3 2023 $1.19M 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q1 2023 $102K 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $102K 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024

Estrella Immunopharma, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.19M +$785K +192% 01 Jul 2023 30 Jun 2024 10-KT 25 Mar 2025
2023 $410K 01 Jul 2022 30 Jun 2023 10-K 27 Sep 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.